MBX.TO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 13:37):

Stats
Today's Volume	5 500.00
Average Volume	72 316.00
Market Cap	48.48M
EPS	$0 ( 2024-02-14 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0.275 ( 1999-09-02 )
Next Dividend	$0 ( N/A )
P/E	11.83
ATR14	$0 (0.00%)

Microbix Biosystems Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Microbix Biosystems Inc Financials

Annual	2023
Revenue:	$16.51M
Gross Profit:	$7.48M (45.30 %)
EPS:	$-0.000300

Q4	2023
Revenue:	$4.26M
Gross Profit:	$1.43M (33.42 %)
EPS:	$0.0146

Q3	2023
Revenue:	$5.53M
Gross Profit:	$2.34M (42.37 %)
EPS:	$-0.00560

Q2	2023
Revenue:	$4.22M
Gross Profit:	$2.53M (59.91 %)
EPS:	$-0.00120

Financial Reports:

No articles found.

Microbix Biosystems Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Microbix Biosystems Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.09 - Potential for dividend initiation, but uncertain (18.22%)

Information

First Dividend	$0.275	1999-09-02
Last Dividend	$0.275	1999-09-02
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.275	--
Avg. Dividend % Per Year	0.00%	--
Score	2.58	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.09
Div. Directional Score	8.58	--

Next Divdend (Est)
(2024-04-19)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.58

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
XEN.TO	Dividend Junior	2023-09-25	Quarterly	18	1.60%
POU.TO	Dividend King	2023-09-14	Monthly	30	3.65%
FCQH.TO	Dividend Junior	2023-06-27	Quarterly	6	0.54%
ZUE.TO	Dividend Junior	2023-06-28	Quarterly	15	0.72%
TPE.TO	Dividend Junior	2023-06-28	Quarterly	9	1.34%
LIFE.TO	Dividend King	2023-08-30	Monthly	7	4.35%
CRT-UN.TO	Dividend King	2023-09-28	Monthly	11	3.04%
XMU.TO	Dividend Junior	2023-06-26	Quarterly	13	0.69%
QSR.TO	Dividend Knight	2023-09-19	Semi-Annually	10	1.00%
FSV.TO	Dividend Knight	2023-09-28	Quarterly	10	0.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.157	1.500	6.87	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0957	1.200	6.81	8.17	[0 - 0.3]
returnOnEquityTTM	0.144	1.500	9.52	10.00	[0.1 - 1]
payoutRatioTTM	0.0278	-1.000	9.72	-9.72	[0 - 1]
currentRatioTTM	8.53	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.99	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	4.60	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.164	-1.500	7.27	-10.00	[0 - 0.6]
interestCoverageTTM	5.12	1.000	9.21	9.21	[3 - 30]
operatingCashFlowPerShareTTM	0.00702	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.000274	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.221	-1.500	9.12	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.558	1.000	4.03	4.03	[0.2 - 0.8]
operatingProfitMarginTTM	0.200	1.000	8.01	8.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.159	1.000	-0.226	-0.226	[0.2 - 2]
assetTurnoverTTM	0.611	0.800	9.26	7.41	[0.5 - 2]
Total Score				13.07

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.99	1.000	8.69	0	[1 - 100]
returnOnEquityTTM	0.144	2.50	9.69	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.000274	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00702	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.0278	1.500	9.72	-9.72	[0 - 1]
pegRatioTTM	-0.137	1.500	-4.25	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0427	1.000	-1.431	0	[0.1 - 0.5]
Total Score				4.09

Microbix Biosystems Inc

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.